SCHEMBL12469879

SCHEMBL12469879

C=C(COC(=O)c1c(Cl)cccc1Cl)C(=O)NCc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 2/20 1.00
CASP3 P42574 2/20 0.55
CASP6 P55212 2/20 0.55
CASP8 Q14790 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.50
RAB9A P51151 2/20 0.47
GAA P10253 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
LMNA P02545 1/20 0.43
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
THRB P10828 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RECQL P46063 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16672088 0.85 TXNRD1 (0.73) TXNRD1CASP3CASP6CASP8SMN1; SMN2
SCHEMBL24585205 0.82 TXNRD1 (0.70) TXNRD1SMN1; SMN2TDP1KMT2AMEN1
SCHEMBL12469853 0.81 TXNRD1 (1.00) TXNRD1CASP3CASP6CASP8GAA
SCHEMBL16638892 0.79 TXNRD1 (0.64) TXNRD1CASP3CASP6CASP8RAB9A
SCHEMBL12438732 0.75 TXNRD1 (0.59) TXNRD1SMN1; SMN2L3MBTL1KMT2AMEN1
SCHEMBL24585199 0.74 TXNRD1 (0.58) TXNRD1SMN1; SMN2GAAL3MBTL1KMT2A
SCHEMBL24585189 0.74 KMT2A (0.67) TXNRD1L3MBTL1KMT2AMEN1LMNA
SCHEMBL553682 0.73 TXNRD1 (0.56) TXNRD1SMN1; SMN2GAAL3MBTL1KMT2A
SCHEMBL1269639 0.73 CYP1A2 (0.56) TXNRD1SMN1; SMN2GAAL3MBTL1KMT2A
SCHEMBL6801086 0.72 ALDH1A1 (0.63) TXNRD1CASP3CASP6CASP8RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9018255-B2 Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) 2015-04-28 US claimed
EP-2627628-B1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM INST CHEMII ORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) 2015-04-15 EP claimed
US-20130317102-A1 Novel Esters of (Acyloxymethyl)Acrylamide, a Pharmaceutical Composition Containing Them, and Their use as Inhibitors of the Thioredoxin - Thioredoxin Reductase System Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) 2013-11-28 US claimed
EP-2627628-A1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM Instytut Chemii Fizycznej Polskiej Akademii Nauk (PL) 2013-08-21 EP claimed
WO-2012050465-A1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) 2012-04-19 WO claimed
US-9018255-B2 Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) 2015-04-28 US disclosed
EP-2627628-B1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM INST CHEMII ORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) 2015-04-15 EP disclosed
EP-2627628-B1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM INST CHEMII ORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) 2015-04-15 EP disclosed
US-20130317102-A1 Novel Esters of (Acyloxymethyl)Acrylamide, a Pharmaceutical Composition Containing Them, and Their use as Inhibitors of the Thioredoxin - Thioredoxin Reductase System Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) 2013-11-28 US disclosed
EP-2627628-A1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM Instytut Chemii Fizycznej Polskiej Akademii Nauk (PL) 2013-08-21 EP disclosed
WO-2012050465-A1 NOVEL ESTERS OF (ACYLOXYMETHYL)ACRYLAMIDE, A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE AS INHIBITORS OF THE THIOREDOXIN - THIOREDOXIN REDUCTASE SYSTEM Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) 2012-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130317102-A1 Novel Esters of (Acyloxymethyl)Acrylamide, a Pharmaceutical Composition Containing Them, and Their use as Inhibitors of the Thioredoxin - Thioredoxin Reductase System TXNRD3, TXNRD1, TXN TXNRD1 2/4885CASP3 697/4885CASP6 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.